My research includes basic, translational, and clinical research in cerebrovascular diseases, in particular stroke, cerebral aneurysms, and subarachnoid hemorrhage. My research has been supported by continuous NIH funding since 2009. I have successfully translated NIH K08 faculty funding to NIH R01 and U01 funding. In 2021, I was the #1 highest NIH-funded neurosurgeon according to Blue Ridge Institute for Medical Research.

My research is focused on studying:

1) the basic mechanisms of cerebral aneurysm repair: NIH R01 NS083673 (PI: B. Hoh, 2014-19), NIH K08 NS067058 (PI: B. Hoh, 2009-14), NIH LRP (2009-14)

2) inflammatory pathways for cerebral aneurysm formation and rupture: NIH R01 NS110710 (PI: B. Hoh, 2020-24), NIH R56 NS110710 (PI: B. Hoh, 2019-20)

3) mechanisms for acute neural injury after subarachnoid hemorrhage: NIH R01 NS124620 (PI: B. Hoh, 2022-2027)

4) anti-thrombotics to prevent recurrent stroke from symptomatic intracranial atherosclerotic stenosis: U01 NS117450 (multi-PI: B. Hoh, M. Chimowitz, 2021-2026)

5) pterygopalatine fossa nerve blockade for acute headache treatment in subarachnoid hemorrhage patients: NIH U01NS124613 (pending, multi-PI: K. Busl, C. Maciel, C. Smith, B. Hoh, M. Fava, A. Troxel)